Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Amino-myo-inositol derivatives have been found to be potent inhibitors of glucocerebrosidase (GCase), the β-glucosidase enzyme deficient in Gaucher disease (GD). When tested using lymphoblasts derived from patients with GD homozygous for N370S or L444P mutations, the compounds enhanced GCase activit...

书目详细资料
Main Authors:	Trapero, A, González-Bulnes, P, Butters, T, Llebaria, A
格式:	Journal article
语言:	English
出版:	2012

相似书籍

Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
由: Trapero, A, et al.
出版: (2011)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
由: Benjamin McMahon, et al.
出版: (2016-01-01)

Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
由: Wang, G, et al.
出版: (2009)

Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
由: Wang, G, et al.
出版: (2012)

Effect of macrophage-targeted glucocerebrosidase(alglucerase) on hypolipidaemia of type 1 Gaucher disease(GD)
由: Mistry, P, et al.
出版: (1997)

Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
由: Kato, A, et al.
出版: (2016)

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
由: Désiré, J, et al.
出版: (2014)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
由: Figueiredo, Lílian L. S., et al.
出版: (2024)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
由: Lílian L. Souza Figueiredo, et al.
出版: (2024-10-01)

Gaucher disease.
由: Butters, T
出版: (2007)

Concise and enantioselective synthesis of the aminocyclitol core of hygromycin A.
由: Donohoe, T, et al.
出版: (2005)

Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients
由: Keatdamrong Janpipatkul, et al.
出版: (2024-10-01)

High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.
由: Ehud Goldin, et al.
出版: (2012-01-01)

A myo-inositol dehydrogenase involved in aminocyclitol biosynthesis of hygromycin A
由: Michael O. Akintubosun, et al.
出版: (2024-03-01)

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
由: Wendy Westbroek, et al.
出版: (2016-07-01)

Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
由: Diot, J, et al.
出版: (2011)

INVESTIGATIONS ON THE RESISTANCE OF COMMENSAL SWINE ESCHERICHIA COLI TO SOME AMINOGLYCOSIDES-AMINOCYCLITOLS
由: Valentina Urumova, et al.
出版: (2016-03-01)

Second-Generation Pharmacological Chaperones: Beyond Inhibitors
由: My Lan Tran, et al.
出版: (2020-07-01)

Hydrophobic Rose Bengal Derivatives Exhibit Submicromolar-to-Subnanomolar Activity against Enveloped Viruses
由: Anna A. Rubekina, et al.
出版: (2022-11-01)

Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
由: Jan Philipp Dobert, et al.
出版: (2024-07-01)

A NOVEL SYNTHETIC AND RECOMBINANT GLUCOCEREBROSIDASE FOR GAUCHER DISEASE: IN SILICO MOLECULAR EVOLUTION AND GENE THERAPY APPROACHES TO ENHANCE ENZYME ACTIVITY
由: LLS Figueiredo, et al.
出版: (2023-10-01)

Different and unusual presentation of Gaucher’s disease with the same mutation in the glucocerebrosidase enzyme (F266L) in two patients: a case report
由: Bijan Keikhaei, et al.
出版: (2024-11-01)

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
由: Brumshtein, B, et al.
出版: (2007)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
由: Alba Navarro-Romero, et al.
出版: (2022-10-01)

Comparative Study of Erythrocyte Sedimentation Rate after Aminoglycoside and Aminocyclitol Treatment in Goats (Capra hircus)
由: Toncho DINEV, et al.
出版: (2016-07-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
由: Tae-Un Han, et al.
出版: (2020-05-01)

Unveiling the Role of Cholesterol in Subnanomolar Ouabain Rescue of Cortical Neurons from Calcium Overload Caused by Excitotoxic Insults
由: Dmitry A. Sibarov, et al.
出版: (2023-08-01)

N,Zn-Doped Fluorescent Sensor Based on Carbon Dots for the Subnanomolar Detection of Soluble Cr(VI) Ions
由: Enoch Kwasi Adotey, et al.
出版: (2023-02-01)

Mitochondrial dysfunction associated with glucocerebrosidase deficiency
由: Matthew E. Gegg, et al.
出版: (2016-06-01)

Glucocerebrosidase and its relevance to Parkinson disease
由: Jenny Do, et al.
出版: (2019-08-01)

Imino sugar therapy for type 1 Gaucher disease.
由: Priestman, D, et al.
出版: (2000)

Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration
由: Nikolay T. Tzvetkov, et al.
出版: (2017-01-01)

Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells
由: Yusuke Naito, et al.
出版: (2023-10-01)

Gaucher Disease and Gaucher Cells
由: Sevgi Gözdaşoğlu
出版: (2015-05-01)

Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
由: Diana A. Olszewska, et al.
出版: (2020-06-01)

Pharmacological Chaperone Therapy for Pompe Disease
由: Marc Borie-Guichot, et al.
出版: (2021-11-01)

Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria
由: Andrés D. Klein, et al.
出版: (2023-10-01)

Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.
由: Lindsey T. Lelieveld, et al.
出版: (2022-05-01)

Glucocerebrosidase involvement in Parkinson Disease and other Synucleinopathies
由: Maria Rosario Almeida
出版: (2012-04-01)

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
由: Neumann, J, et al.
出版: (2009)